Clinical Trial Update: Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed the safety and tolerability of rivastigmine with add-on memantine in patients with probable Alzheimer's disease; the study is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Memantine (memantine)
• Rivastigmine (Rivastigmine)

Snippet

Sponsor: Novartis | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED